Dravet Syndrome - 27 Studies Found No longer available : Stiripentol in Dravet Syndrome : Dravet Syndrome : 2012-02-09 : Drug: stiripentol Stiripentol up to 30 mg/kg/day to control seizures Available : Compassionate Use of Stiripentol in Dravet Syndrome : Dravet Syndrome : 2013-04-15 : Drug: Stiripentol Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth Completed : Verapamil as Therapy for Children and Young Adults With Dravet Syndrome : Dravet Syndrome : 2012-05-24 : Drug: Verapamil Verapamil will be prepared as a solution. Completed : Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome : Dravet Syndrome : 2016-08-23 : Device: measure of neuronal excitability Available : Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome : Dravet Syndrome : 2013-11-07 : Drug: Stiripentol Withdrawn : Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome : Dravet Syndrome : 2014-06-02 : Drug: Clobazam Other Name: Onf Terminated : Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome : Dravet Syndrome : 2014-07-09 : Drug: Clobazam Other Name: Onfi® Completed : A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome : Dravet Syndrome : 2016-06-13 : Drug: ZX008 - 0.8 mg/kg/day ZX Not yet recruiting : Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome : Dravet Syndrome : 2014-12-12 : Drug: Cannabidiol Oral Solution Enrolling by invitation : An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome : Dravet Syndrome : 2016-06-13 : Drug: ZX008 (Fenfluramine Hydrochloride) Next >>>
